| 영문 | epidemic parotitis, mumps | 한글 | 볼거리, 유행귀밑샘염 |
|---|---|---|---|
| 설명 | 주로 소아에서 일어나고, 그 결과로 지속성 면역을 주는 전염성의 paramyxovirus 병. 흡기에 의해서 감염되는데, 가장 농후한 바이러스감염은 침샘내에 생기며, 특히 턱밑샘이나 혀밑샘보다도 귀밑샘이 더욱 심하다. 잠복기는 18~22일이다. 감염은 약 75%의 증례에서 증상을 나타낸다. 이들 중 귀밑샘염은 70%에서, 수막염은 10~15%(이들 중 반수에서 무증상성 수액세포 증가증이 동반된다)에서 일어난다. 부고환고환염이 사춘기 후의 남성에서 생기지만 그 후에 불임증을 속발하는 일은 드물다. 그 외의 증상은 보다 드물게 나타나는데 이자염, 관절염, 심근염, 난소염, 갑상샘염 및 젖샘염 등이 있다. 발열과 환부의 유통성 염증은 최초의 2일간에 가장 현저하고 다음 4~5일이 지나면 서서히 가라앉는다. 동시에 한 부위 이상을 침습하는 수도 있으며 가끔 속발적으로 침습되고 질환의 전 경과는 2~3주에 이른다. 부수되는 영속성의 신경학적 손상을 동반하는 수막뇌염은 드물다. |
||
| 영문 | vaccination | 한글 | 예방접종 |
|---|---|---|---|
| 설명 | 1.인위적으로 능동면역을 성립시켜서 감염에 대한 저항력을 높이기 위하여 약독화병원체(생백신) 또는 사균, 불활성 화백신 등을 접종하는 것을 말한다. 당초 종두는 젠너(Jenner)에 의해서 발견된 마마 예방법에 관한 접종을 의미했으나 현재에는 널리 감염증이나 전염병의 병원균 그 자체가 일부를 접종해서 비감염자를 면역하는 것을 의미한다. 예방접종으로 표준화되었으며, 항원으로서 백신이 사용된다. 예방접종으로 감염이 억제되지만 피부에 나타나는 이상이나 두드러기모양 홍반 등의 피부발진이나 뇌염 등의 부작용이 나타날 수 있으므로 주의를 요한다. 2.예방접종에 쓰이는 항원에는 크게 나누어 세균성 항원과 바이러스성 항원이 있는데, 세균성 항원에는 사멸된 전체 세균(백일해 백신 등), 병원체가 체외로 배출하는 독소를 멸독한 변성독소(톡소이드)(디프테리아-파상풍 등), 독력을 약화시킨 생세균체(BCG 등)등이 있고, 바이러스성 항원에는 생약독화한 것(소아마비)과 사멸된 백신(인플루엔자) 등이 포함된다. 한국에서는 전염병 예방법에 두창-디프테리아-백일해-장티푸스-콜레라-파상풍-결핵 등 일곱 개 질병에 관하여 정기 예방접종을 시행하도록 되어 있다. 또 대한소아과학회에서는 BCG-소아마비-디프테리아-백일해-파상풍-홍역-유행성귀밑샘염(볼거리)-풍진-일본뇌염 등 아홉 개 예방접종을 정하고 있다. |
||
| vacc | vaccination |
|---|---|
| VS | vaccination scar; vaccine serotype; vagal stimulation; vasospasm; venesection; ventricular septum; v... |
| MMR | 1) Measles, Mumps, Rubella; 홍역, 멈프스, 풍진 2) Mass Miniature Radiography... |
| MMR | mass miniature radiography; masseter muscle rigidity; maternal mortality rate; measles-mumps-rubella... |
| MUMPS | Massachusetts General Hospital Utility Multi-Programming System |
| PV | post vaccination |
|---|---|
| MMR | MEASLES: mumps-rubella |
| MMR | Measles, mumps and rubella |
| MMR | Measles-Mumps-Rubella vaccine |
| MuV | Mumps virus |
primary's area
| vaccination, mumps | See Vaccination, MMR. Vaccination, pneumococcal pneumonia: this vaccine, which prevents one of the most common and severe forms of pneumonia, is usually given only once in a lifetime, usually after the age of 55, to someone with ongoing lung problems (such as chronic obstructive pulmonary disease (copd) or asthma) or other chronic diseases (including those involving the heart and kidneys). This vaccination would rarely be given to children. (12 Dec 1998) |
|---|
| measles, mumps and rubella vaccine | A combination of live attenuated measles, mumps, and rubella viruses in an aqueous suspension; used for immunization against the respective diseases. (05 Mar 2000) |
|---|---|
| metastatic mumps | Mumps complicated by involvement of organs other than parotid glands, such as the testis, breast, or pancreas. (05 Mar 2000) |
| mumps | An infectious acute viral disease affecting the parotid glands. The gonads, meninges and pancreas can also be affected. The causative agent is a paramyxovirus. Humans are the only natural host for this disease. Common symptoms include weakness, fever, sore throat, malaise and puffiness to the cheeks (due to parotid gland swelling). Patients are contagious 1 day prior to the onset of swelling until the swelling is gone. Recovery is generally in 2 weeks. (27 Sep 1997) |
| mumps immunization | The standard MMR vaccine is given to prevent measles, mumps and rubella (german measles). The mmr vaccine is now given in two dosages. The first should be given at12-15 months of age. The second vaccination should be given at 4-6 years (or, alternatively, 11-12 years) of age. most colleges require proof of a second measles or mmr vaccination prior to entrance. Most children should receive mmr vaccinations. Exceptions may include children born with an inability to fight off infection, some children with cancer, on treatment with radiation or drugs for cancer, on long term steroids (cortisone). People with severe allergic reactions to eggs or the drug neomycin should probably avoid the mmr vaccine. Pregnant women should wait until after delivery before being immunised with mmr. People with HIV or aids should normally receive mmr vaccine. Measles, mumps, and rubella vaccines may be administered as individual shots, if necessary, or as a measles-rubella combination. (12 Dec 1998) |
| mumps in pregnancy | It has been stated, we believe erroneously, that mumps is dangerous when contracted during pregnancy. For example, vetter (infect med 14:730-733, 1997), citing a single 1980 article, writes: mumps infection during the first trimester of pregnancy can increase the rate of spontaneous abortion. Congenital anomalies associated with mumps infection during pregnancy include endocardial fibroelastosis; imperforate anus; spina bifida; and auditory, optic, and urogenital deformities. However, shepard in his authorative catalog of teratogenic agents (j hopkins u press, 8th edition, 1995) does not consider that mumps merits inclusion as a proven or even possible teratogenic agent, that is as an agent capable of causing a spontaneous abortion (a miscarriage) or causing congenital malformations (the baby is born with birth defects). Furthermore, mumps does not even warrant mention in smith's recognizable patterns of human malformation (by kl jones, wb saunders co., 5th edition, 1997), a key standard text on dysmorphology (the study of malformations). Based also on our review of the facts available at this time (oct, 1997), we conclude that there is insufficient evidence to label mumps as a particular hazard in pregnancy. (12 Dec 1998) |
| mumps meningoencephalitis | A usually benign nervous system infection arising during the active phase of clinical mumps parotiditis. (05 Mar 2000) |
| mumps orchitis | <pathology> A mumps infection that has affected the testicles. Approximately 20-35% of postpubertal males with mumps will develop this complication. (27 Sep 1997) |
| mumps sensitivity test | A skin test for sensitivity to mumps, in which inactivated mumps virus is used as antigen. (05 Mar 2000) |
| mumps skin test antigen | A sterile suspension of killed mumps virus in isotonic sodium chloride solution, used to determine susceptibility to mumps or to confirm previous exposure. (05 Mar 2000) |
| mumps vaccine | A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had mumps or been immunised with live mumps vaccine. Children are usually immunised with measles-mumps-rubella combinatiom vaccine. (12 Dec 1998) |
| mumps virus | The type species of rubulavirus that causes an acute infectious disease in humans, affecting mainly children. Transmission occurs by droplet infection. (12 Dec 1998) |
| mumps virus vaccine | Vaccine containing live, attenuated mumps virus prepared in chick embryo cell cultures. See: measles, mumps, and rubella vaccine. (05 Mar 2000) |
| immunization, mumps | See Immunization, MMR. (12 Dec 1998) |
| vaccination | <procedure> The introduction of vaccine into the body for the purpose of inducing immunity. Coined originally to apply to the injection of smallpox vaccine, the term has come to mean any immunising procedure in which vaccine is injected. Origin: L. Vacca = cow (18 Nov 1997) |
| vaccination, anthrax | A series of six shots over six months and booster shots annually, the anthrax vaccine now in use in the usa was first developed in the 1950s and approved by the food and drug administration for general use in 1970. It is produced by the michigan biologic products institute of michigan's department of health and is given routinely to veterinarians and others working with livestock. In december, 1997 it was announced that all us military would receive the vaccine, as do the military in the uk and russia, the reason being concern that anthrax might be used in biologic warfare. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|